EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Artificial Internalizing Receptors: Intracellular Delivery of Cargo Through Bio‐Orthogonal Recognition

Ane Bretschneider Søgaard, Rikke Fabech Hansson, Anne Selch Tvilum, Alexander N Zelikin iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202402472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Ane Bretschneider Søgaard und 3 weiteren Autor:innen. Beteiligte Einrichtung: iNano Interdisciplinary Nanoscience Center, Aarhus University, Aarhus, 8000, Denmark. Hauptthemen laut MEDLINE: Receptors, Artificial, Drug Delivery Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novo Nordisk Fonden, Danmarks Frie Forskningsfond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug targeting is a methodology that helps to overcome the side effects of therapeutic molecules. However, insufficient targeting specificity and the on‐target/off‐site delivery leave much room for improvement in the targeting endeavors. One approach to enhance the specificity of drug targeting is to engineer artificial receptors with recognition ligands not observed in nature. To this end, artificial internalizing receptors that feature cholesterylamine as the artificial pull‐in mechanism, and an anti‐fluorescein antibody as the exofacial recognition and capture tool are developed. Fluorescein labeling is among the most routine techniques in biochemistry and can readily provide a way to make cognate derivatives for receptor‐mediated endocytosis using these artificial receptors. Herein, the synthesis and the structure‐activity relationship for these artificial receptors are detailed, their potency and efficacy in mediating drug delivery for the antibody‐drug conjugates are illustrated, and the scope and limitations of targeting the chemically engineered cells via artificial receptors are investigated. Taken together, the presented data explore an innovative approach to drug targeting and contribute to the development of techniques in cell engineering using the tools of chemistry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, ArtificialDrug Delivery SystemsHumansEndocytosisAnimalsFluoresceinImmunoconjugates

Stichwörter der Autor:innen

artificial receptorschemical cell engineeringhapteninternalization

Substanzen

Receptors, ArtificialFluoresceinImmunoconjugates

Autor:innen und Institutionen

  • iNano Interdisciplinary Nanoscience Center, Aarhus University, Aarhus, 8000, Denmark.
  • Department of Chemistry, Aarhus University, Aarhus, 8000, Denmark.

ORCID-Profile: Alexander N Zelikin

Förderung

  • Novo Nordisk Fonden
  • Danmarks Frie Forskningsfond

Zitieren

APA

Søgaard, A. B., Hansson, R. F., Tvilum, A. S., & Zelikin, A. N. (2024). Artificial Internalizing Receptors: Intracellular Delivery of Cargo Through Bio‐Orthogonal Recognition. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402472

Vancouver

Søgaard AB, Hansson RF, Tvilum AS, Zelikin AN. Artificial Internalizing Receptors: Intracellular Delivery of Cargo Through Bio‐Orthogonal Recognition. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202402472

BibTeX
@article{Sgaard2024,
  author = {Søgaard, Ane Bretschneider and Hansson, Rikke Fabech and Tvilum, Anne Selch and Zelikin, Alexander N},
  title = {Artificial Internalizing Receptors: Intracellular Delivery of Cargo Through Bio‐Orthogonal Recognition},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202402472}
}
Kostenlos starten →